Reply to Letter to the Editor: 'Can Differences in Non-Vitamin K Antagonist Oral Anticoagulant Preferences Result in Varying Clinical Outcomes in Patients with Atrial Fibrillation?'

Anatol J Cardiol. 2024 Jan;28(1):70. doi: 10.14744/AnatolJCardiol.2023.4097.
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / chemically induced
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Warfarin